Taysha Gene Therapies (TSHA) Research & Development (2022 - 2025)
Historic Research & Development for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to $25.7 million.
- Taysha Gene Therapies' Research & Development rose 7225.34% to $25.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.8 million, marking a year-over-year increase of 2117.81%. This contributed to the annual value of $66.0 million for FY2024, which is 1624.4% up from last year.
- Per Taysha Gene Therapies' latest filing, its Research & Development stood at $25.7 million for Q3 2025, which was up 7225.34% from $20.1 million recorded in Q2 2025.
- In the past 5 years, Taysha Gene Therapies' Research & Development registered a high of $38.2 million during Q1 2022, and its lowest value of $11.8 million during Q3 2023.
- Over the past 4 years, Taysha Gene Therapies' median Research & Development value was $15.6 million (recorded in 2025), while the average stood at $18.4 million.
- Per our database at Business Quant, Taysha Gene Therapies' Research & Development plummeted by 6722.54% in 2023 and then soared by 7225.34% in 2025.
- Over the past 4 years, Taysha Gene Therapies' Research & Development (Quarter) stood at $12.7 million in 2022, then decreased by 0.2% to $12.7 million in 2023, then increased by 20.84% to $15.3 million in 2024, then skyrocketed by 67.99% to $25.7 million in 2025.
- Its Research & Development was $25.7 million in Q3 2025, compared to $20.1 million in Q2 2025 and $15.6 million in Q1 2025.